[ad_1]
NEW YORK (Reuters Health) – Vitamin D supplementation can help treat drug-resistant tuberculosis, according to a recent British study published in the European Journal of Reporter Journal, indicating that 10 million people have contracted TB and that 1, 6 million have died. The disease in the world in 2017, according to estimates of the World Health Organization.
Researchers at Queen Mary University in London followed 1,850 cases of tuberculosis patients on antibiotics, half of whom were on vitamin D supplementation, and found that vitamin D supplementation helped accelerate the elimination of TB bacteria lungs. In patients, compared to those who did not.
"Multidrug-resistant TB is increasing worldwide and is known to be difficult to treat compared to normal TB," said Professor Adrian Martino, director of the research team, quoted by the US Department of Labor as saying. Anatolian news agency. "Our study raises the possibility that vitamin D is very safe and inexpensive, so it may be advantageous for this group of hard-to-treat patients to adopt a new therapeutic approach," he added. "The addition of vitamin D Antibiotic therapy allows us to boost immunity to help the body eliminate TB, rely on antibiotics alone to kill bacteria. "
MDR-TB affects about 500,000 people a year and causes 150,000 deaths worldwide, according to the study. Noting that current treatments for multidrug-resistant TB drugs are expensive and often toxic because of their serious side effects.
Vitamin D can be compensated by eating foods such as salmon, sardines, tuna, fish oil, cow's liver and eggs, or by eating vitamin supplements available in pharmacies.
The body uses vitamin D to maintain bone health and absorb calcium effectively. In addition, lack of vitamin can increase the risk of injury in people with osteoporosis and bone malformations, cancer and inflammation, and disrupt the body's immune system.
[ad_2]
Source link
